AltPep
  • About
    • Our Company
    • Leadership
    • Board of Directors
    • Advisory Board
  • Our Approach
    • Our Approach
    • Product Pipeline
    • Scientific Publications
  • Team
  • News
    • News and Articles
    • Video Library
  • Careers
  • Contact
Select Page

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases

Jan 14, 2021

Read Geekwire article: Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases  

AltPep announces that Chad Robins joined AltPep Board of Directors

Sep 20, 2020

Chad is the co-founder and CEO of Adaptive Biotechnologies, a commercial-stage biotech company in Seattle that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease.

AltPep completes round of initial seed funding

Sep 15, 2020

AltPep completes round of initial seed funding.

AltPep sets up first lab in Fluke Hall at the University of Washington CoMotion Incubator

Sep 15, 2019

Seattle-based life sciences consulting and incubator company, Intutive-X joins AltPep launch

Apr 17, 2019

GeekWire—To fight Alzheimer’s disease, Univ. of Washington researchers target plaque-causing proteins

Apr 16, 2019

View article here.

University of Washington exclusively licenses intellectual property developed in Daggett Lab

Apr 16, 2019

Medical News Today—Alzheimer’s: Synthetic protein blocks toxic beta-amyloid

Apr 16, 2019

View article here.

Genetic Engineering & Biotechnology News—Alzheimer’s Disease Toxicity Halted by Synthetic Peptides

Apr 15, 2019

View article here.

Research America, Investment in Research Saves Lives and Money Series—Alzheimer’s Fact Sheet

Apr 15, 2019

View fact sheet here.
Next Entries »

Recent Posts

  • From Discovery to Design: Toward Early Detection and Treatment of Alzheimer’s Disease
  • Promising data from large Alzheimer’s study bodes well for this Seattle startup
  • Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash
  • Review: Amyloid-β Oligomers: Multiple Moving Targets
  • AltPep Receives FDA Breakthrough Device Designation for SOBA-AD, A Simple Blood Test for the Detection of Alzheimer’s Disease

Recent Comments

    • Home
    • Our Company
    • Our Approach
    • Careers
    • Contact
    • Linkedin
    • Twitter
    AltPep Corporation | 100 Northeast North Lake Way | Seattle, WA 98105